Ruby Nanomed

Description: Ruby Nanomed's automated process detects metastases early, offering a fast, cost-effective 2-hour prognostic report for therapy monitoring & patient stratification.

Country: Italy

Based in: Braga

Founded: 2018

Funding Stage: Series A/B

Tags: ['Health Care', 'Muscle-invasive', 'Circulating']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.